Back to Search
KATHLEEN LEAHY, DO
DO
Physical Medicine & Rehabilitation Physician
NPI: 1609805076IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
9776(NH)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
OTHER
Class of 1992
Research & Publications (20)
Reducing the energy density of multiple meals decreases the energy intake of preschool-age children.
PMID 19064504·Am J Clin Nutr·2008
2-rct
Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
PMID 18457826·Eur J Pharmacol·2008
7-preclinical
Reductions in entrée energy density increase children's vegetable intake and reduce energy intake.
PMID 18451770·Obesity (Silver Spring)·2008
2-rct
An atypical case of fatal zygomycosis: simultaneous cutaneous and laryngeal infection in a patient with a non-neutropenic solid prostatic tumor.
PMID 18404912·Ear Nose Throat J·2008
5-case
Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo.
PMID 18371452·Cell Stem Cell·2008
7-preclinical
Reducing the energy density of an entrée decreases children's energy intake at lunch.
PMID 18155988·J Am Diet Assoc·2008
2-rct
Domestic violence, maternal parenting, maternal mental health, and infant externalizing behavior.
PMID 17176188·J Fam Psychol·2006
8-other
The influence of community violence on the functioning of women experiencing domestic violence.
PMID 16134049·Am J Community Psychol·2005
8-other
Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b.
PMID 15183108·Exp Eye Res·2004
7-preclinical
A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
PMID 12766257·J Pharmacol Exp Ther·2003
7-preclinical
NIC/Q 2000: establishing habits for improvement in neonatal intensive care units.
PMID 12671159·Pediatrics·2003
4-observational
Pharmacology of celecoxib in rat brain after kainate administration.
PMID 12183639·J Pharmacol Exp Ther·2002
7-preclinical
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
PMID 11830509·Cancer Res·2002
7-preclinical
Economic implications of neonatal intensive care unit collaborative quality improvement.
PMID 11134429·Pediatrics·2001
3-trial
Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network.
PMID 11134428·Pediatrics·2001
8-other
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
PMID 11059745·Cancer Res·2000
7-preclinical
adapt78 protects cells against stress damage and suppresses cell growth.
PMID 10898938·Arch Biochem Biophys·2000
7-preclinical
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
PMID 10728691·Cancer Res·2000
7-preclinical
Upregulation of COX-2 during cardiac allograft rejection.
PMID 10653836·Circulation·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9 WASHINGTON PL STE 201
BEDFORD, NH 03110 - Phone
- (603) 644-5133
Quick Facts
- NPI
- 1609805076
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile